These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 33054767)
1. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case. Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767 [TBL] [Abstract][Full Text] [Related]
2. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow. Wang X; Ng CS; Chen C; Yu G; Yin W Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a report of five cases]. Shao SH; Gu HY; Lin DL; Shi HL; Zhang YJ; Li YJ Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):762-766. PubMed ID: 31594039 [No Abstract] [Full Text] [Related]
4. VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION. Salman AR; Ferenchak K; Olsen TW; Smith WM; Ketterling RP; McPhail ED; Salomao DR; Dalvin LA Retin Cases Brief Rep; 2023 Sep; 17(5):572-576. PubMed ID: 37490925 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report. Zheng X; Xie J; Zhou X Int J Clin Exp Pathol; 2015; 8(7):8598-602. PubMed ID: 26339440 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults]. Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995 [TBL] [Abstract][Full Text] [Related]
8. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Perry AM; Warnke RA; Hu Q; Gaulard P; Copie-Bergman C; Alkan S; Wang HY; Cheng JX; Bacon CM; Delabie J; Ranheim E; Kucuk C; Hu X; Weisenburger DD; Jaffe ES; Chan WC Blood; 2013 Nov; 122(22):3599-606. PubMed ID: 24009234 [TBL] [Abstract][Full Text] [Related]
9. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review. Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661 [TBL] [Abstract][Full Text] [Related]
10. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update. Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological characteristics of natural killer cell enteropathy: report of two cases and review of literature]. Huo YJ; Zhang DD; Zhou L; Li CF; Wang GN; Zhao WG; Zhang YP; Jian XY; Huang HF; Li WC Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):108-113. PubMed ID: 35152628 [No Abstract] [Full Text] [Related]
12. Practical Approach to the Histologic Diagnosis of Gastrointestinal Lymphomas Through the First-line Marker Battery of CD20, CD3, CD30, and Epstein-Barr Virus-encoded RNAs. Kim EK; Yang WI; Ryu HJ; Ji HL; Yoon SO Adv Anat Pathol; 2020 Mar; 27(2):75-86. PubMed ID: 31913182 [TBL] [Abstract][Full Text] [Related]
13. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade? Wang XG; Yin WH; Wang HY Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808 [TBL] [Abstract][Full Text] [Related]
14. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report. Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood]. Jin Y; Zhou XG; He LJ; Xie JL; Zheng YY; Zhang YN; Zhang SH Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):600-8. PubMed ID: 20079188 [TBL] [Abstract][Full Text] [Related]
16. Self-regressing oral CD30-positive, EBV-negative, T-cell lymphoproliferative lesions. A poorly understood process highlighted by ominous clinicopathologic features and indolent behavior. Argyris PP; Ho D; Islam MN; Khurram SA; Courville EL; Morgan S; Sundick B; Soliman M; Janakiram M; Gopalakrishnan R; Koutlas IG Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Dec; 132(6):698-707. PubMed ID: 34526251 [TBL] [Abstract][Full Text] [Related]
17. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract. Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618 [TBL] [Abstract][Full Text] [Related]
18. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract. Soderquist CR; Patel N; Murty VV; Betman S; Aggarwal N; Young KH; Xerri L; Leeman-Neill R; Lewis SK; Green PH; Hsiao S; Mansukhani MM; Hsi ED; de Leval L; Alobeid B; Bhagat G Haematologica; 2020 Jul; 105(7):1895-1906. PubMed ID: 31558678 [TBL] [Abstract][Full Text] [Related]